As of June 30, 2026, Banvit Bandirma Vitaminli Yem Sanayii A.S. carries a market capitalization of 17.81B, placing it among publicly traded companies globally. Its enterprise value stands at 17.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 17.81B |
| Enterprise Value | 17.56B |
As of June 30, 2026, Banvit Bandirma Vitaminli Yem Sanayii A.S. has 100.02M shares outstanding.
| Shares Outstanding | 100.02M |
These figures are as of June 30, 2026.
| PB Ratio | 1.42 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | -5.65 |
| P/OCF Ratio | -6.14 |
As of June 30, 2026, Banvit Bandirma Vitaminli Yem Sanayii A.S. maintains a current ratio of 1.35, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.35 |
| Quick Ratio | 0.42 |
| Debt / Equity | 35.36 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 4,855.75 |
Over the twelve months ended June 30, 2026, Banvit Bandirma Vitaminli Yem Sanayii A.S. recorded an income tax benefit of -195.60M rather than an expense, typically from losses, carryforwards, or the release of a tax provision.
| Income Tax | -195.60M |
As of the close on October 22, 2026, Banvit Bandirma Vitaminli Yem Sanayii A.S.'s stock has declined approximately 35.82% over the past 52 weeks. The 50-day moving average sits at 141.49, while the 200-day moving average is 157.56.
| 52-Week Price Change | -35.82% |
| 50-Day Moving Average | 141.49 |
| 200-Day Moving Average | 157.56 |
As of June 30, 2026, Banvit Bandirma Vitaminli Yem Sanayii A.S. holds 4.71B in cash and equivalents against 4.45B in total debt, resulting in a net debt position of -360.81M. Total book value stands at 12.59B, with working capital of 3.91B providing operational flexibility.
| Cash & Cash Equivalents | 4.71B |
| Total Debt | 4.45B |
| Net Debt | -360.81M |
| Equity (Book Value) | 12.59B |
| Book Value Per Share | 125.86 |
| Working Capital | 3.91B |
Banvit Bandirma Vitaminli Yem Sanayii A.S. produced -2.90B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -249.12M in capital expenditures, free cash flow totaled -3.15B - equivalent to -31.50 per share.
| Operating Cash Flow | -2.90B |
| Capital Expenditures | -249.12M |
| Free Cash Flow | -3.15B |
| FCF Per Share | -31.50 |
These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -17.68: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -10.34, meaning Banvit Bandirma Vitaminli Yem Sanayii A.S. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -10.34 |
| FCF Yield | -17.68 |
Banvit Bandirma Vitaminli Yem Sanayii A.S.'s most recent stock split took place on August 14, 2008 with a 4:5 split ratio.
| Last Split Date | 8/14/2008 |
| Split Ratio | 4:5 |
Already premium?